BIOMAT Database Logo BIOMAT Database Logo

A field test for the detection of antibodies to human immunodeficiency virus types 1 and 2 in serum or plasma. 1996

A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Saliva Diagnostic Systems, Inc., Vancouver, Washington 98682-2444, USA.

In response to the need for simple and rapid tests for infectious diseases, we have devised a test for antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 which resembles many contemporary strip-style pregnancy tests in format and ease of use. The test was evaluated with 2,928 serum specimens (1,541 reactive and 1,387 nonreactive) collected and tested at a Mexico City hospital clinic and was compared with a laboratory assay (Abbott) performed simultaneously. The sensitivity and specificity of the test using these serum specimens were 99.68 and 99.71%, respectively (before the code of the blinded study was broken). This compares with 100% sensitivity and 97.55% specificity with the laboratory assay (specificity upon reassay after the code was broken, 99.21%). In a survey of HIV-2 specimens, reactive (positive) specimens were detected in 51 of 51 cases. The test was examined with 21 commercially available (HIV-1) seroconversion panels. The performance of the test was comparable to that of a group of Food and Drug Administration-approved (antibody-based) HIV tests.

UI MeSH Term Description Entries
D011934 Reagent Strips Narrow pieces of material impregnated or covered with a substance used to produce a chemical reaction. The strips are used in detecting, measuring, producing, etc., other substances. (From Dorland, 28th ed) Reagent Strip,Strip, Reagent,Strips, Reagent
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2.
January 2008, Journal of clinical laboratory analysis,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2.
June 1999, International journal of STD & AIDS,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2.
August 2003, Journal of clinical microbiology,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Multicenter evaluation of a fully automated screening test, VIDAS HIV 1 + 2, for antibodies to human immunodeficiency virus types 1 and 2.
October 1994, Journal of clinical microbiology,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodies.
March 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Immunoassay for detection of antibodies to simian immunodeficiency virus and human immunodeficiency virus in serum.
April 1996, Laboratory animal science,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2.
September 1997, Clinical and diagnostic laboratory immunology,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Correlation between saliva and serum for human immunodeficiency virus 1 and 2 antibodies using a rapid test system.
July 1995, Annals of the Academy of Medicine, Singapore,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Rapid, simple, and reliable doctor's office test for antibodies to human immunodeficiency virus 1 in serum.
July 1990, Clinical chemistry,
A Burgess-Cassler, and G Barriga Angulo, and S E Wade, and P Castillo Torres, and W Schramm
Detection of antibodies to human immunodeficiency virus (HIV-1) with the particle agglutination test.
July 1992, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
Copied contents to your clipboard!